ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

No reading has been made of this study yet; what is shown is how the rules link it today.

8 links0 made here, not in the record4 judgments1 judge (the rules as one: Rule based)2 record changes seen
Rule basedRecord updated on ClinicalTrials.gov
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT04514497Testing the Addition of anAnti-cancer Drug, BAY1895344, to UsualChemotherapy for AdvancedStage Solid Tumors, With aSpecific Focus on PatientsWith Small Cell LungNational Cancer Institute (NCIPhase 1 · active not recruitinRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Nov 13 · ClinicalTrials.gov record · Version of 2026-11-13Nov 18 · ClinicalTrials.gov record · Version of 2026-11-18Version of 2026-11-18CONDITIONSSmall Cell Lung CarcinomaThe registry's MeSH filing›As of now · Rule based · Main conditionMain conditionNeoplasm MetastasisThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Carcinoma, NeuroendocrineThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Lung NeoplasmsThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Pancreatic NeoplasmsThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.DRUGSBAY 1895344Entry “Elimusertib”, read by our name…›As of now · Rule based · BackgroundBackgroundIrinotecanEntry “Irinotecan Hydrochloride”, rea…›As of now · Rule based · BackgroundBackgroundTopotecanEntry “Topotecan Hydrochloride”, read…›As of now · Rule based · BackgroundBackground

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Small Cell Lung Carcinoma

From the registry record1 judgment on this link
Main condition (R9), from the registry to what was judged
RegistrySmall Cell Lung Carcinoma, as filedthe registry files the study under it
→judged

All judgments on this study

WhenLinkJudgeDecisionState
Nov 13The record itselfClinicalTrials.gov recordVersion of 2026-11-13Record change
Nov 18The record itselfClinicalTrials.gov recordVersion of 2026-11-18Record change
As of nowSmall Cell Lung CarcinomaRule based · main-condition ruleMain conditionCurrent
As of nowBAY 1895344Rule based · role ruleBackgroundCurrent
As of nowIrinotecanRule based · role ruleBackgroundCurrent
As of nowTopotecanRule based · role ruleBackgroundCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.